Angiotensin‐converting enzyme inhibitors increase anti‐fibrotic biomarkers in African Americans with left ventricular hypertrophy

Abstract Angiotensin‐converting enzyme inhibitors (ACEi) are part of the indicated treatment in hypertensive African Americans. ACEi have blood pressure‐independent effects that may make them preferred for certain patients. We aimed to evaluate the impact of ACEi on anti‐fibrotic biomarkers in Afric...

全面介紹

書目詳細資料

Principais autores:	Cesar A.Romero, Shobi Mathew, Benjamin Wasinski, Brian Reed, Aaron Brody, Rachelle Dawood, Michael J. Twiner, Candace D. McNaughton, Rafael Fridman, John M. Flack, Oscar A. Carretero, Phillip D. Levy
格式:	Artigo
語言:	Inglês
出版:	Wiley 2021-05-01
叢編:	The Journal of Clinical Hypertension
主題:	ACE inhibitors Ac‐SDKP African American collagen left ventricular hypertrophy MMP‐1
在線閱讀:	https://doi.org/10.1111/jch.14206
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!